Atopix Therapeutics, Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Oxford United Kingdom (2012)
Status: Acquired by Chiesi (2016)

Organization Overview

First Clinical Trial
2013
NCT02002208
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree